5月7日 - ** 制药公司Viatris VTRS.O股价上涨6.7%，报17.02美元
** 该公司公布 (link) 第一季度经调整后每股收益为59美分，较上年同期增长18%，得益于中国及新兴市场的强劲增长
** 据伦敦证券交易所集团（LSEG）汇编的数据，分析师此前预期经调整后每股收益为50美分
** 第一季度营收达35.2亿美元，超出33.6亿美元的预期
** 中国业务营收增长22%至6.801亿美元，超出5.477亿美元的预期
** 巴克莱分析师表示：“我们认为，该公司业绩已实现转亏为盈这一事实尚未得到充分认可，且其公布的营收指引现已转为正增长”
** 计入当日涨幅，VTRS今年以来累计上涨38.9%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.